Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

Fabrication of Chitosan and Poly-Acrylic Acid Complexes as Osmogent for Swellable Nanoporous Osmotic Pump

Manish Balasaheb Phad, Avinash Kondalkar, Priti Tagde,

NRI Institute of Pharmacy, Bhopal

ABSTRACT

In present study on controlled porosity osmotic tablet of Irbesartan was performed. The study involved two stages, at first stage; optimization of sodium chloride in the core tablet to optimize the release of water insoluble Irbesartan, while the second stage involved the formulation and evaluation of the CPOP (chitosan and poly-Acrylic acid osmotic pump) and study effect of different concentrations of swelling polymer (chitosan and carbopol 934 P). Irbesartan is a angiotensin II given in the treatment of hyprtension. Irbesartan is water insoluble drug so by optimization of sodium chloride in the core tablet, concentration of chitosan and carbopol 934 P in the proper weight ratios modifies the release of water insoluble Irbesartan in order to make it controlled release approach for 10 hrs.. The study reveals successful performance of optimization technique for the development of controlled porosity osmotic tablet drug delivery. When the release rate of osmotic tablets, it was found that increse3 in concentration of chitosan and carbopol 934P, the drug release was found to be increased.

Keywords: Osmotic Tablet, Chitosan, Carbopol 934P


[Full Text Article]